Skip to main navigation Skip to search Skip to main content

Cost-effectiveness analysis of infliximab and adalimumab for Crohn's disease.

  • D. Hughes
  • , D.A. Hughes
  • , K. Bodger
  • , T. Kikuchi

    Research output: Contribution to conferencePaper

    Original languageEnglish
    Publication statusPublished - 1 Apr 2008
    EventWelsh Health Economics Group, Swansea University, Wales, UK -
    Duration: 3 Jan 0001 → …

    Conference

    ConferenceWelsh Health Economics Group, Swansea University, Wales, UK
    Period3/01/01 → …

    Cite this